NF-κB is upregulated in prostate cancer, whereas the knockdown of NF-κB decreased the expression of survivin, which is an important anti-apoptotic protein and NF-κB target gene, and induced capase-3 cleavage (Zhuang et al., 2014). This evidence concerns the gene BIRC5 and prostate carcinoma.